key: cord-0922627-9ru7qim9 authors: Chang, Pai-Ling; Lin, Chia-Yi; Chen, Cheng-Pin; Lin, Yi-Chun; Hu, Hui-Chun; Cheng, Shu-Hsing; Cheng, Chien-Yu title: Clinical Validation of an Automated Reverse Transcription-Insulated Isothermal PCR Assay for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2 date: 2021-02-01 journal: J Microbiol Immunol Infect DOI: 10.1016/j.jmii.2021.01.005 sha: 2ea6dac807de2d0cb903ec3dd49f7096947d07d6 doc_id: 922627 cord_uid: 9ru7qim9 To determine clinical performance of the single-target SARS-CoV-2 orf 1ab reverse transcription-insulated isothermal PCR (RT-iiPCR) assay, the positive percentage agreement between this assay and a laboratory real-time RT-PCR assay was 96.8% (30 of 31; 95% confidence interval [CI], 90.5% - 100%) and the negative percentage agreement was 97.1% (67 of 69; 95% CI, 93.1% - 100%). Coronavirus disease 2019 (COVID- 19) is an emerging viral respiratory disease 8 that was first identified in Wuhan, China, in December 2019. [1] As of November 26, 9 2020, COVID-19 is an ongoing pandemic disease and affected more than 215 10 countries and territories, and more than 59 million cases and 1.4 million deaths. The etiological agent of COVID-19 is severe acute respiratory syndrome 20 coronavirus 2 (SARS-CoV-2), a member of the Betacoronavirus genus in 21 Coronaviridae family. Following the emergence of SARS-CoV-2, several molecular 22 detection methods and serological assays were quickly developed and deployed 23 internationally through an international collaborative laboratory response. [9,10] 24 Currently, real-time RT-PCR (RT-PCR) is the primary method for laboratory 25 diagnosis of SARS-CoV-2 infection; however, RT-PCR assays are costly, demand 26 expensive instrumentation, and require a dedicated laboratory environment with 27 technically skilled personnel. [11] Consequently, simple and rapid methods are 28 required to meet the needs of near-point-of-need SARS-CoV-2 detection. Fluorescent 29 probe hydrolysis-based insulated isothermal PCR (iiPCR) for amplification and 30 detection of nucleic acid has been described. [ Analyzer automates magnetic bead-based nucleic acid extraction as well as 40 fluorescence-based iiPCR amplification and detection to offer a simple sample-in-41 answer-out protocol. Qualitative results are available in less than 1.5 hours. Taking 42 advantage of this system, one single-target RT-iiPCR assay, namely POCKIT™ 43 Central SARS-CoV-2 (orf 1ab) Premix Reagent, targeting orf 1ab for the detection of Table 1 ). The samples were tested first with 60 the real-time RT-PCR assay. After the results were available, residual samples were 61 subjected to the SARS-CoV-2 orf 1ab RT-iiPCR assay. 62 The degree of agreement between the two assays was assessed by kappa analysis reference method) and negative percent agreement was calculated as (number 106 negative by both methods)/(number negative by reference method). 107 Clinical data and specimens were obtained from the patients with In this study, the SARS-CoV-2 orf 1ab RT-iiPCR assay was shown to have 137 performance comparable to that of the reference laboratory real-time RT-PCR assay 138 by side-by-side testing of oropharyngeal swab samples collected from patients with 139 acute or chronic respiratory illness including patients who previously tested positive 140 for SARS-CoV-2. High positive agreement (96.8%) and high negative agreement 141 (97.1% ) were found between the two assays. Discrepancy between two different 142 assays are most likely due to that the target was present at low titers. However, further 143 analysis of the discrepant samples was not possible because the amounts of the 144 samples remained were too low. Testing of more clinical samples is being coordinated 145 to further support the clinical specificity and sensitivity of the orf 1ab RT-iiPCR. 146 The POCKIT™ Central iiPCR system qualitative results are available for 8 147 samples in less than 1.5 hours after the run start. Real-time RT-PCR, being able to 148 process at least 96 tests in one run, has in general higher throughput than the 149 POCKIT™ Central system. However, with the needs for an additional step for nucleic 150 acid extraction which took about 1.5 hours, and for testing at least two SARS-CoV-2 151 genes to aid COVID-19 diagnosis, the laboratory real-time RT-PCR testing protocol 152 took about 3 to 4 hours to provide results for 30 samples. 153 The reference real-time RT-PCR assay was designed to test at least 2 viral genes 154 to ensure reactivity for SARS-COV-2 since only few sequences of the virus became 155 available at the time of assay development. The data presented in this study demonstrated that the performance of the single-168 target SARS-CoV-2 orf 1ab RT-iiPCR assay was comparable to that of the reference 169 real-time RT-PCR assay while was able to provide much faster results than the real-170 time RT-PCR. 171 Financial support 172 Clinical characteristics of 138 hospitalized 182 patients with 2019 novel coronavirus-infected pneumonia in Wuhan World Health Organization: Coronavirus disease 2019 (COVID-19) Situation Prevalence and Duration of Acute Loss of Smell or Taste in COVID-19 Patients Asymptomatic carrier state, acute 189 respiratory disease, and pneumonia due to severe acute respiratory syndrome 190 coronavirus 2 (SARS-CoV-2): Facts and myths The Incubation Period of Coronavirus Disease 193 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and 194 Application Lopinavir/ritonavir Did Not Shorten the 196 Duration of SARS CoV-2 Shedding in Patients With Mild Pneumonia in Olufunke Tolulope Owa. Lopinavir/ritonavir use in Covid-19 infection: is it completely non-beneficial? Detection From Nasopharyngeal Swab Samples by the Roche Cobas 6800 Commercial Serologic Assays for Determination of SARS-CoV-2 IgG Diagnostic detection of 2019-nCoV by real-time RT-PCR Rapid and sensitive detection of infectious 215 bursal disease virus by reverse transcription loop-mediated isothermal 216 amplification combined with a lateral flow dipstick Isothermal PCR based POCKIT Test for Rapid and Easy Detection of White 220 Spot Syndrome Virus Infection in Litopenaeus vannamei. PLoS One. deployable Reverse Transcription-Insulated Isothermal PCR Assay for the 224 Detection of the Middle East Respiratory Syndrome Coronavirus A pan-dengue virus reverse 229 transcription-insulated isothermal PCR assay intended for point-of-need 230 diagnosis of dengue virus infection by use of the POCKIT nucleic acid 231 analyzer A fully automated sample-to-answer PCR system for easy and sensitive 233 detection of dengue virus in human serum and mosquitos PCR Assays for Detection of COVID-19 Virus Detection of 2019 Novel Coronavirus 240 (2019-nCoV) by Real-Time RT-PCR CDC 2019 Novel Coronavirus (2019-nCoV) Real-time RT-PCR Diagnostic Diagnostic Detection of Wuhan 244 Coronavirus 2019 by Real-Time RT-PCR Mutations on COVID-19 diagnostic 250 targets Emerging SARS-CoV-2 mutation hot 252 spots include a novel RNA-dependent-RNA polymerase variant Large scale genomic analysis of 3067 SARS-CoV-2 genomes reveals a clonal geo-distribution and a rich genetic 256 variations of hotspots mutations